Trader's blog

Gilead shares slide after FDA knocks back rheumatoid arthritis drug

Shares of Gilead Sciences (GILD.O) fell 3% after the U.S. Food and Drug Administration declined to approve its experimental rheumatoid arthritis treatment, a major setback for one of the drugmaker’s

Read More

J&J strikes $6.5 billion deal for autoimmune disease specialist Momenta

Johnson & Johnson on Wednesday agreed to buy Momenta Pharmaceuticals Inc for about $6.5 billion to add muscle to its portfolio of drugs for hard-to-treat autoimmune diseases. The deal gives

Read More

Apple tops $2 trillion in market value

(Reuters) – Apple Inc (AAPL.O) became the first publicly listed U.S. company with a $2 trillion stock market value on Wednesday, as Wall Street investors put aside challenges to its

Read More

Oil Prices Fall As OPEC+ Enters Critical Period For Production Deal

Oil prices fell Wednesday as an OPEC+ advisory panel meets during a critical period for its production agreement, while U.S. inventory data signaled weakening demand. The oil group’s Joint Ministerial

Read More

Stocks – Wall Street Opens Mixed as Target, Lowe’s Surge; Dow up 30 Pts

Investing.com — U.S. stock markets opened mixed on Wednesday with ‘old-economy’ indexes outperforming the Nasdaq after another couple of barnstorming quarterly updates from the retail sector. Target (NYSE:TGT) stock rose

Read More